ASSESSMENT OF QUALITY OF LIFE IN PATIENTS TREATED WITH CHEMO-RADIATION THERAPY FOR OESOPHAGEAL CARCINOMA
Main Article Content
Keywords
ESOPHAGEAL CANCER, QUALITY OF LIFE
Abstract
As per GLOBOCAN 2022 data, Esophageal cancer ranks eleventh in terms of incidence (5,11,054 new cases) and seventh in mortality overall (4,45,391 deaths), the latter signifying that esophageal cancer is responsible for one in every 18 cancer deaths in 2022, worldwide.[1]
The geographic variation in esophageal cancer incidence substantially differs between the 2 most common histological subtypes (squamous cell carcinoma [SCC] and adenocarcinoma [AC]).
References
2. Brow LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin Nam 2002;11(2):235–256.
shttps://ncdirindia.org/All_Reports/Report_2020/resources/NCRP_2020_2012_16. Pdf
3. Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol. 2004; 31:554– 5. [PubMed] [Google Scholar]
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Aishwarya Sharma
Resident doctor, Department of Radiation Oncology, Government Cancer Hospital, Mahatma Gandhi Memorial Medical College, Indore, M.P., India
Prof. (Dr.) Ramesh Arya
Head of the Department and Medical Superintendent, Government Cancer Hospital, Mahatma Gandhi Memorial Medical College, Indore, M.P., India
Dr Preety Jain
Associate Professor, Department of Radiation Oncology, Government Cancer Hospital, Mahatma Gandhi Memorial Medical College, Indore, M.P., India
Dr Karuna Abgad
Resident doctor, Department of Radiation Oncology, Government Cancer Hospital, Mahatma Gandhi Memorial Medical College, Indore, M.P., India